Thiamine Dosing Recommendations
Thiamine dosing depends critically on clinical context: for healthy adults, 1.1-1.2 mg/day orally is adequate; for mild deficiency, 10 mg/day orally; for acute high-risk situations including Wernicke encephalopathy, 500 mg IV three times daily (1,500 mg/day total); and for most hospitalized patients at risk, 100-300 mg IV daily. 1
Baseline Requirements for Healthy Individuals
- Healthy adults require 1.1-1.2 mg/day orally (RDA), with an estimated average requirement (EAR) of 0.9-1.0 mg/day 2, 1
- Children and teenagers need 0.7-1.2 mg/day (EAR), with RDAs of 0.9-1.2 mg/day 2, 1
- Preterm and term infants on parenteral nutrition require 0.35-0.50 mg/kg/day 1
Parenteral Nutrition Maintenance
- Standard parenteral nutrition formulations contain 2-6 mg/day thiamine, with most European preparations containing 2.5-3.5 mg 2
- ASPEN recommends 6 mg/day to accommodate patients receiving high-dose glucose who may have very high requirements 2, 1
- This 3 mg dose in standard multivitamin preparations is adequate to maintain normal thiamine status even in patients with compromised intestinal absorption 3
Mild Deficiency (Oral Route)
For suspected chronic deficiency without acute disease, oral administration is adequate: 1
- 10 mg/day orally for one week, followed by 3-5 mg/day orally for at least 6 weeks 1
- Alternative regimen: 10-20 mg IM three times daily for up to two weeks, followed by oral multivitamin with 5-10 mg thiamine daily for one month 4
- Maintenance after proven deficiency: 50-100 mg/day orally 1
Moderate Risk Situations (Oral Route)
- Chronic diuretic therapy: 50 mg/day orally 1
- Post-bariatric surgery prophylaxis: 50 mg once or twice daily from B-complex supplement for first 3-4 months postoperatively 1
- Uncomplicated alcohol dependence (low risk): 250-500 mg/day orally for 3-5 days, then 100-250 mg/day 5
High-Risk/Acute Situations (IV Route)
The IV route is mandatory for acute disease, suspected inadequate intake, alcohol-related gastritis (poor absorption), active vomiting, or any suspicion of Wernicke encephalopathy: 1
Hospitalized/Critical Illness
- 100-300 mg/day IV for general high-risk hospitalized patients 1
- 100-300 mg/day IV for 3-4 days from admission for emergency/intensive care patients 1
- Continuous renal replacement therapy: 100 mg/day 1
Alcohol Use Disorder
- Routine alcohol withdrawal: 100 mg/day orally for all patients, continuing for 2-3 months after withdrawal resolution 1
- High-risk patients (malnourished, severe withdrawal): 100-300 mg/day IV 1
- Suspected Wernicke encephalopathy in alcohol use disorder: 250-300 mg IV twice daily for 3-5 days 5
Wernicke Encephalopathy (Established Diagnosis)
- 500 mg IV three times daily (1,500 mg/day total) for encephalopathy of uncertain etiology including Wernicke encephalopathy 1, 4
- Continue for 3-5 days, then transition to oral thiamine 250-1,000 mg/day 5
- High-dose thiamine (≥500 mg) appears safe and efficacious, with 73% of patients showing symptom resolution or improvement 6
Refeeding Syndrome
- 300 mg IV before initiating nutrition therapy, then 200-300 mg IV daily for at least 3 more days 1
Post-Bariatric Surgery with Complications
- Prolonged vomiting, dysphagia, poor intake, or fast weight loss: 200-300 mg daily IV immediately 1
- Neurological symptoms require immediate supplementation 1
Critical Timing Consideration
Thiamine must be administered BEFORE any glucose-containing IV fluids to prevent precipitating acute Wernicke encephalopathy, as thiamine is essential for glucose metabolism 1, 4
- Patients with marginal thiamine status receiving dextrose should receive 100 mg thiamine in each of the first few liters of IV fluid 4
Special Clinical Scenarios
"Wet" Beriberi with Myocardial Failure
- Must be treated as emergency cardiac condition with slow IV administration 4
- 10-20 mg IM three times daily for up to two weeks 4
Neuritis of Pregnancy
- 5-10 mg IM daily when vomiting precludes oral therapy 4
Infantile Beriberi
Safety and Monitoring
- No established upper limit for toxicity; excess thiamine is excreted in urine 1
- High IV doses rarely cause anaphylaxis 1
- Doses >400 mg may induce nausea, anorexia, and mild ataxia 1
- Preferred biomarker: RBC or whole blood thiamine diphosphate (ThDP), as it is not affected by inflammation 1
- Monitoring recommended in suspected deficiency with cardiomyopathy, prolonged diuretic treatment, prolonged medical nutrition, post-bariatric surgery, refeeding syndrome, or encephalopathy 1
Common Pitfalls to Avoid
Guideline-concordant thiamine supplementation is rare in clinical practice, with only 2.1% of patients with encephalopathy receiving dosing consistent with Royal College of Physicians guidelines 7. The traditional 100 mg daily dosing for Wernicke encephalopathy is inadequate; updated guidelines recommend much higher doses (500 mg three times daily) 1, 6. However, some evidence suggests even a single 100 mg dose may be biologically sufficient, though clinical protocols recommend higher doses for safety 8.